Overview

Fespixon Cream for the Treatment of Pressure Injury in Sacrum Wound

Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
Evaluate the efficacy and safety of Fespixon cream for the treatment of pressure injury in sacrum wound.
Phase:
Phase 4
Details
Lead Sponsor:
Taipei Medical University WanFang Hospital
Collaborators:
Kaohsiung Medical University Chung-Ho Memorial Hospital
Oneness Biotech Co., Ltd.